Screener Summaries Updates Institutions Sign In More Updates › Other Events › DARE Other Events · Jul 24, 2026
Daré Bioscience, Inc. furnished a corporate presentation dated July 24, 2026, for use in meetings with securities… DARE Dare Bioscience, Inc.
Daré Bioscience, Inc. furnished a corporate presentation dated July 24, 2026, for use in meetings with securities market participants. The company is a clinical-stage biopharmaceutical company focused on women's health. }{
More from Dare Bioscience, Inc. Nasdaq notifies Daré Bioscience of non-compliance with $1.00 minimum bid price requirement Oct 2, 2026 On August 14, 2026, Dare Bioscience entered into a securities purchase agreement to sell 4,379,581 shares of common… Aug 17, 2026 Daré Bioscience reported financial results for the quarter ended June 30, 2026 Aug 13, 2026 Dare Biosciences, Inc. was notified by Nasdaq Listing Qualifications Staff that its common stock is subject to… Jul 17, 2026 At its annual meeting on June 11, 2026, stockholders approved an amendment to the 2022 Stock Incentive Plan to… Jun 12, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
